Blackstone’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-35,726
Closed -$1.16M – 678
2026
Q1
$1.16M Buy
+35,726
New +$1.15M ﹤0.01% 235

Other funds holding VKTX

Blackstone's VKTX Position: Q2 2026 in Review

Blackstone sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 35,726 shares — an estimated $1.16M sold.

Blackstone first reported a position in VKTX in Q1 2026 and held it in 1 quarter. The position peaked at $1.16M in Q1 2026. 438 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Blackstone reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Blackstone sold 35,726 Viking Therapeutics shares in Q2 2026, an estimated $1.16M.
  • Blackstone first reported a position in Viking Therapeutics in Q1 2026 and held it in 1 quarter.
  • Blackstone's Viking Therapeutics position peaked at $1.16M in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.